Using these techniques, one study found that myeloid cells localized to mesenchymal-like regions of GBM drive T cell exhaustion via IL-10 release, and that this T cell function was rescued with Janus kinase-signal transducer and activator of transcription (JAK/STAT) inhibition, providing a potential therapeutic opportunity (57). This evidence concerns the gene IL10 and glioblastoma.